TB treatment time cut by a third

TB treatment time cut by a third

A new four-month treatment course for drug-sensitive tuberculosis (the most common form of TB by far) is as safe and effective as the current six-month treatment course that has been in use since the 1980s, according to findings from a large new study. Amy Green reports.

Read More

What is behind SA’s higher TB numbers?

What is behind SA’s higher TB numbers?

A World Health Organization report published last week showed more people are falling ill with tuberculosis in South Africa than previously thought – but also that the country’s treatment success rate for dangerous drug-resistant forms of the disease have improved. Amy Green asks what’s behind these numbers.

Read More

IN-DEPTH: The slow motion race for a TB vaccine

IN-DEPTH: The slow motion race for a TB vaccine

In recent months, the world has seen unprecedented investment in new vaccines. Yet, while a COVID-19 vaccine proven to be safe and effective may be less than a year away, a new tuberculosis vaccine might only be ready to be rolled out in a decade, despite a massive head start over COVID-19. Amy Green takes a closer look at the race for a new vaccine for the world’s top infectious disease killer.

Read More

Editorial: As COVID-19 numbers fall, much remains uncertain

Editorial: As COVID-19 numbers fall, much remains uncertain

How many people have actually died of COVID-19 in South Africa and what do we know about the possibility of a second wave? As the first, and hopefully the only, substantial wave of infections and death recedes, Spotlight Editor Marcus Low assesses the many remaining uncertainties.

Read More

Some TB patients still required to take pills in front of witnesses

Some TB patients still required to take pills in front of witnesses

Some tuberculosis patients in South Africa are still required to take their pills in front of a healthcare worker or family member. Is this a justified means of ensuring people take their medicine, or is it an invasion of personal autonomy? Elri Voigt asked local TB experts.

Read More